Health product recall

Vitrakvi: Presence of contamination in affected lot

Last updated

Summary

Product
Vitrakvi
Issue
Health products - Contamination
What to do

Consult your health care professional if you have any health concerns.

Affected products

Brand Product Name Market Authorization Dosage Form Strength Lot
Vitrakvi Vitrakvi DIN 02490331 Solution LAROTRECTINIB (LAROTRECTINIB SULFATE) 20mg/ml 2133134

Issue

Presence of contamination in affected lot

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Healthcare establishments

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Bayer Inc.

2920 Matheson Blvd E, Mississauga

ON, Canada, L4W 5R6

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-74568